GlassScriptPhysician profile
Katherine R See
NPI 1891132312
$501.66
in general payments reported to CMS, 2019-2025
7 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.06 · 2021: $88.02 · 2023: $237 · 2024: $18.12 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327 · Entertainment: $75.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.81 |
| Entertainment | $75.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $135.02 | 2023 | Total30, Precision 1, Dailies Total1 |
| Abbvie INC. | $102.24 | 2023 | Durysta |
| Horizon Therapeutics Plc | $88.02 | 2021 | |
| Optos, INC. | $75.77 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Rxsight INC | $71.43 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Harrow Eye, LLC | $18.12 | 2024 | Vevye |
| Biotissue Holdings INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine See listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.